The assigned single protein target of the DRUGMATRIX assay is the inhibition of the Thromboxane Synthetase enzyme, with PGH2 as its substrate. The assay uses Platelet as the cell type and Homo sapiens as the organism. It is an In vitro test, and its assay type description is Binding. Does this molecule show effectiveness in this assay?